Literature DB >> 3536242

Lineage heterogeneity in acute leukaemia: acute mixed-lineage leukaemia and lineage switch.

S A Stass, J Mirro.   

Abstract

Until recently, lineage fidelity was thought to be preserved in leukaemic cells, which by available tests showed surface markers and enzymatic patterns characteristic of an appropriate normal cell lineage and stage of differentiation. Our data indicate that this theory is too restrictive. If leukaemogenesis occurs in pluripotent progenitors in a relatively high percentage of cases, we would propose a model in which lymphoid and myeloid differentiation antigens are expressed simultaneously until the progenitor cell commits to a single lineage. Lineage commitment could involve external factors, e.g. growth factors (Sherr et al, 1985), that cause genes specific for the opposite lineage to be 'switched off'. The control of gene expression in mammalian cells and the specific chromosomal sites of genes coding for the various lineage-associated markers remain uncertain. However, recent studies indicate that most, if not all, leukaemic cells contain chromosomal abnormalities, many involving rearrangements of DNA (Williams et al, 1986). Since the control of eukaryotic gene expression is known to involve numerous sequence elements, some acting at a distance from the site of transcription (Dynan and Tjian, 1985), genetic perturbations within the cell (e.g. a reciprocal translocation) could be expected to deregulate certain genes, leading to their under- or overexpression analogous to activation of the c-myc oncogene by the 8;14 translocation in Burkitt's lymphoma. Thus, an almost infinite variety of cell lineage-related phenotypes could be expected from this mechanism alone, even if the transforming event did not involve a pluripotent stem cell. Also, we have hypothesized that enzymes such as TdT, a DNA polymerase that catalyses polymerization of deoxyribonucleotides without a DNA template, could serve as a modifier of DNA sequences, permitting otherwise inactive genes to be expressed (Stass and Mirro, 1985). It is interesting that most cases of childhood acute mixed-lineage leukaemia are TdT positive, even though this is not true for the chronic leukaemias of adults. It is now clear that unusual combinations of myeloid and lymphoid cell lineages are much more common in acute leukaemia than have been generally recognized or suspected. The traditional division of the acute leukaemias into ALL and AML may not be the most accurate way to represent this class of haematological malignancies. That mixed-lineage leukaemia may require alternative therapy is a clinically important observation and underscores the need for comprehensive testing of blast cells at diagnosis.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3536242

Source DB:  PubMed          Journal:  Clin Haematol        ISSN: 0308-2261


  14 in total

1.  Establishment and characterization of new B-cell precursor leukemia cell line NALM-35.

Authors:  Yoshinobu Matsuo; Hans G Drexler; Akira Harashima; Nobuharu Fujii; Fumihiko Ishimaru; Kunzo Orita
Journal:  Hum Cell       Date:  2002-12       Impact factor: 4.174

2.  Features of squamous and adenocarcinoma in the same cell in a xenografted human transitional cell carcinoma: evidence of a common histogenesis?

Authors:  P J Russell; E J Wills; J Philips; J Wass; M Jelbart; P Gregory; D Raghavan
Journal:  Urol Res       Date:  1988

3.  Immunophenotyping of acute myeloid leukaemia: relevance of analysing different lineage-associated markers.

Authors:  F Lo Coco; D Pasqualetti; M Lopez; E Panzini; A Gentile; R Latagliata; B Monarca; G De Rossi
Journal:  Blut       Date:  1989-05

4.  Treatment of adult acute lymphoblastic leukaemia using an intensive chemotherapy protocol.

Authors:  R Liang; T K Chan; G T Chan; D Todd
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 5.  Routine immunophenotyping of acute leukaemias.

Authors:  H G Drexler; S M Gignac; J Minowada
Journal:  Blut       Date:  1988-12

6.  cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins.

Authors:  J M Lelias; C N Adra; G M Wulf; J C Guillemot; M Khagad; D Caput; B Lim
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

7.  Rearrangements of c-myc and c-abl genes in tumour cells in Burkitt's lymphoma.

Authors:  S Casares; J M Rodríguez; A Martin; A Parrado
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

8.  TdT expression in acute myeloid leukaemia. Haemopoietic immaturity or maturational asynchrony?

Authors:  A N Stark; I D MacKarill; H J Limbert; P Evans; C S Scott
Journal:  Blut       Date:  1988-01

9.  Lineage switch from precursor B cell acute lymphoblastic leukemia to acute monocytic leukemia at relapse.

Authors:  Osamu Imataki; Hiroaki Ohnishi; Genji Yamaoka; Takeshi Arai; Akira Kitanaka; Yoshitsugu Kubota; Yoshio Kushida; Toshihiko Ishida; Terukazu Tanaka
Journal:  Int J Clin Oncol       Date:  2010-02       Impact factor: 3.402

10.  Acute myelogenous leukemia switch lineage upon relapse to acute lymphoblastic leukemia: a case report.

Authors:  Elisa Dorantes-Acosta; Farina Arreguin-Gonzalez; Carlos A Rodriguez-Osorio; Stanislaw Sadowinski; Rosana Pelayo; Aurora Medina-Sanson
Journal:  Cases J       Date:  2009-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.